Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
The divisor is the scaling factor used to recalibrate an index when its components change. Understanding why divisor matters helps explain why market cap shifts don't always move the index in lockstep.
28,625 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
XLV faces a pivotal year as it tracking to beat the S&P 500 in 2026. Analysts say two factors that will decide its fa...
EverCommerce stock has faced volatility in 2026. With a focus on cash flow, analysts weigh a path to a $12 target, de...
A closer look at JEPQ reveals a persistent gap between monthly income and total returns. The premium income ETF pays ...
Gemini Space Station stock dropped sharply after a downgrade spurred by profitability concerns and cautious guidance....
When headlines hint at a fallout between two A-list friends, the impact isn’t just gossip. This article digs into the...
When a small-cap tech company reports results that miss expectations, the stock often takes a hit. This piece dives i...
New projections warn the Social Security trust fund could exhaust by 2032, risking benefit cuts unless Congress acts....
Bitcoin breaks through the $67,000 level as sentiment improves and risk-on behavior returns to crypto markets. HYPE a...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...
Dogecoin has volatile history and meme-driven momentum. Here are three grounded reasons I won’t be buying in 2026, pl...
Mega-cap tech names are offering ballast as markets wobble, but the rally is fragile and depends on earnings momentum...